Overview

A Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous Lesion

Status:
Completed
Trial end date:
2019-12-20
Target enrollment:
Participant gender:
Summary
A Prospective, Single-Arm, Open-Label, Phase II Study to Evaluate the Efficacy and Safety of Photodynamic Therapy Using Radion™-pdt in Patients with Oral Precancerous Lesion (Oral Verrucous Hyperplasia or Oral Erythroleukoplakia).
Phase:
Phase 2
Details
Lead Sponsor:
Pharma Power Biotec Co., Ltd.